RHOBTB2
Basic information
Region (hg38): 8:22987417-23020509
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy, 64 (Strong), mode of inheritance: AD
- developmental and epileptic encephalopathy, 64 (Moderate), mode of inheritance: AD
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AR
- developmental and epileptic encephalopathy, 64 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 64 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 29276004 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- Chorea;Dystonic disorder (1 variants)
- Developmental and epileptic encephalopathy, 64 (1 variants)
- RHOBTB2-related disorder (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RHOBTB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 171 | 14 | 187 | |||
missense | 215 | 58 | 38 | 323 | ||
nonsense | 11 | 16 | ||||
start loss | 2 | |||||
frameshift | 14 | 19 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 3 | 20 | 6 | 29 | ||
non coding | 46 | 21 | 70 | |||
Total | 4 | 10 | 256 | 285 | 73 |
Variants in RHOBTB2
This is a list of pathogenic ClinVar variants found in the RHOBTB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-22994530-C-T | Benign (May 14, 2021) | |||
8-22994558-C-T | Benign (Mar 01, 2022) | |||
8-22994583-G-A | RHOBTB2-related disorder | Benign (Aug 18, 2020) | ||
8-22994585-T-C | Uncertain significance (Jun 26, 2023) | |||
8-22994588-A-C | Likely benign (Dec 17, 2024) | |||
8-22994590-G-A | Uncertain significance (Oct 21, 2024) | |||
8-22994597-G-A | Uncertain significance (Nov 22, 2022) | |||
8-22994603-G-A | not specified | Conflicting classifications of pathogenicity (Jun 04, 2024) | ||
8-22994603-G-T | Likely benign (Feb 02, 2025) | |||
8-22994604-C-A | Likely benign (May 29, 2024) | |||
8-22994607-C-T | Likely benign (Oct 18, 2023) | |||
8-22994608-G-A | Likely benign (Apr 17, 2024) | |||
8-22994613-C-T | Likely benign (Aug 29, 2024) | |||
8-22994616-C-T | Likely benign (Oct 23, 2024) | |||
8-22994619-G-C | Uncertain significance (Jun 04, 2024) | |||
8-22994621-A-G | Likely benign (Sep 14, 2022) | |||
8-22994623-A-G | Likely benign (Aug 11, 2024) | |||
8-22994625-C-T | Likely benign (Mar 31, 2021) | |||
8-22994631-A-G | Likely benign (Jun 13, 2023) | |||
8-22994637-C-T | Likely benign (Aug 11, 2024) | |||
8-22994643-A-G | Uncertain significance (Aug 29, 2024) | |||
8-22994645-T-A | Uncertain significance (Sep 29, 2024) | |||
8-22994646-A-G | Likely benign (Feb 15, 2024) | |||
8-22994650-A-G | Likely benign (Sep 10, 2022) | |||
8-22994652-T-C | Likely benign (Jan 30, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RHOBTB2 | protein_coding | protein_coding | ENST00000519685 | 10 | 32783 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0133 | 0.987 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.66 | 322 | 487 | 0.661 | 0.0000325 | 4910 |
Missense in Polyphen | 80 | 191.11 | 0.4186 | 1982 | ||
Synonymous | 0.379 | 189 | 196 | 0.966 | 0.0000130 | 1516 |
Loss of Function | 3.83 | 10 | 34.1 | 0.293 | 0.00000216 | 325 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000634 | 0.000633 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000133 | 0.000132 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- loftool
- 0.614
- rvis_EVS
- -0.97
- rvis_percentile_EVS
- 8.9
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.481
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.946
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rhobtb2
- Phenotype
Gene ontology
- Biological process
- cell morphogenesis;actin filament organization;Rho protein signal transduction;cell migration;actin cytoskeleton organization;positive regulation of actin filament polymerization;actin cytoskeleton reorganization;engulfment of apoptotic cell;regulation of small GTPase mediated signal transduction
- Cellular component
- cytoplasm;cytosol;cytoskeleton;plasma membrane;cell projection
- Molecular function
- GTPase activity;protein binding;GTP binding;protein kinase binding